135M.2 - DEFINITIONS.
135M.2 DEFINITIONS.
1. "Anti-rejection drug" means a prescription drug that
suppresses the immune system to prevent or reverse rejection of a
transplanted organ.
2. "Cancer drug" means a prescription drug that is used to
treat any of the following:
a. Cancer or the side effects of cancer.
b. The side effects of any prescription drug that is used to
treat cancer or the side effects of cancer.
3. "Controlled substance" means the same as defined in
section 155A.3.
4. "Department" means the Iowa department of public health.
5. "Indigent" means a person with an income that is below two
hundred percent of the federal poverty level as defined by the most
recently revised poverty income guidelines published by the United
States department of health and human services.
6. "Medical facility" means any of the following:
a. A physician's office.
b. A hospital.
c. A health clinic.
d. A nonprofit health clinic which includes a federally
qualified health center as defined in 42 U.S.C. § 1396d(l)(2)(B); a
rural health clinic as defined in 42 U.S.C. § 1396d(l)(1); and a
nonprofit health clinic that provides medical care to patients who
are indigent, uninsured, or underinsured.
e. A free clinic as defined in section 135.24.
f. A charitable organization as defined in section 135.24.
g. A nursing facility as defined in section 135C.1.
7. "Pharmacy" means a pharmacy as defined in section 155A.3.
8. "Prescription drug" means the same as defined in section
155A.3, and includes cancer drugs and anti-rejection drugs, but does
not include controlled substances.
9. "Supplies" means the supplies necessary to administer the
prescription drugs donated. Section History: Recent Form
2005 Acts, ch 97, §2